Author name: Yali Friedman

Chinese cloning control required Strict ethical guidelines are needed in China to calm public fears about new cell technologies such […]

Veteran biotech investors offer tips from trenches These market-hardened biotech investors made three basic recommendations: be patient, take profit when

Genome Group Rips Human Cloning Scientists at the Human Genome Organization have condemned plans for human cloning, saying it raises

As Pipelines Wither, Pharma and FDA Explore Whether Microarrays are Ready for Primetime When can the pharmaceutical industry start trusting

Research ‘leak’ hits Genentech Genentech’s shares dropped 12.5 per cent after details of the biotechnology company’s research abstracts for next

Research ‘leak’ hits Genentech Genentech’s shares dropped 12.5 per cent after details of the biotechnology company’s research abstracts for next

As Tony White Reads Resumes, Industry Buzzes Around Core Four It’s been two-and-a-half months since J. Craig walked away from

President Presses Senate to Ban All Human Cloning Declaring that “life is a creation, not a commodity,” Bush pressed the

7 drug makers unveil elderly discounts Under pressure from consumers and lawmakers over drug prices, Abbott Laboratories and six other

Survival of fittest is new mode for biotechs Consolidation won’t slow, and that’s no bad thing, industry watchers say